Oncological Emergencies Flashcards

1
Q

Oncologic emergencies

A
  • Cardiac tamponade
  • Hypercalcemia
  • Spinal cord compression
  • Superior vena cava syndrome
  • Syndrome of inappropriate antidiuretic hormone secretion
  • Tumor lysis syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cardiac tamponade

Definition

A
  • Acute low cardiac output syndrome caused by an excessive accumulation of fluid in the pericardial space or constriction of the pericardium by fibrous tissue, which results in restriction of the heart’s ability to pump
  • Ventricular filling impaired
  • Decreased CO and systemic perfusion
  • Cancer and its treatment are the most common causes of pericardial effusion and subsequent cardiac tamponade.
  • Radiation therapy in large cumulative doses to the chest may cause pericarditis.
  • Certain chemotherapies (anthracyclines) can cause cardiomyopathy and pericardial effusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiac tamponade

Diagnosis

A

Echocardiogram (Most sensitive): Water bottle heart, enlarged heart, widened mediastinum

Chest radiograph and ECG may be used for initial evaluation. This will reveal a “water bottle heart” an enlarged heart and a widened mediastinum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac tamponade

Clinical findings

A

EARLY

  • Dyspnea (most common)
  • Cough, hiccups, dysphagia, or hoarseness
  • Retrosternal chest pain. Pain relieved by leaning over and intensified by lying supine.
  • Agitation, dizziness, or other signs of hypoxia.
  • Weakness and fatigue
  • Muffled or decreased heart sounds, or pericardial friction rub
  • Weak apical pulse

LATE

  • Progressive dyspnea, tachypnea, orthopnea
  • Tachycardia
  • Hepatomegaly, abd pain
  • Progressive restrosternal CP
  • Neck vein distention
  • Decreased SBP, increased DBP
  • Narrowing pulse pressure
  • Pulsus paradoxus > 10 mmHg
  • JVD
  • Edema
  • Cool, clammy skin
  • Changes in LOC
  • Oliguria/anuria
  • Cardiac arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac tamponade

Management

A
  • Diuretics
  • Corticosteroids
  • Oxygen therapy
  • Anxiolytics
  • Analgesics
  • Blood product administration
  • Fluid support
  • Vasoactive drugs (Dopamine)
  • Emergency pericardiocentesis with ECG, echocardiogram or fluoroscopic guidance.
  • Sclerosing the pericardium
  • Pericardial window
  • Total pericardectomy

Nursing Management:

  • Accurate/ongoing assessment: cardiopulmonary and hemodynamic status
  • Early recognition
  • Strict monitoring: v/s, pulse pressure, pulsus paradoxus
  • Respiratory status
  • LOC
  • Fluid balance
  • ECG
  • Volume expanders
  • Elevating HOB
  • Calm environment
  • Education of pt and family regarding procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypercalcemia

Definition

A
  • Greater than normal amounts of calcium in the blood. > 11.0
  • Common etiologies include metastatic bone disease in pts with breast cancer, renal cell, multiple myeloma, lymphoma, or prostate cancer; hyperparathyroidism; prolonged immobility; dehydration; and poor nutrition with low serum albumin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hypercalcemia

Clinical findings

A
  • Bone pain (most common symptom in metastatic disease)
  • Mild hypercalcemia (11-11.9)
    Lethargy, weakness, fatigue, restlessness, difficulty concentrating, polydipsia, polyuria, nocturia, mild hypertension.
  • Moderate hypercalcemia (12-13.9)
    Confusion, drowsiness, cramping, abd pain, muscle weakness, polydipsia, dehydration.
  • Severe hypercalcemia ( >13.9)
    Seizures, coma, ataxia, bradycardia, heart block, renal failure, paralytic ileus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypercalcemia

Diagnostic tests

A
  • Serum calcium > 11 mg/dL
  • Normal 8.5 - 10.5, pts may be asymptomatic up to 14 to 16
  • Elevated urinary calcium
  • Prolonged PR interval
  • Shortened QT interval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hypercalcemia

Management

A
  • Long term: Treating the underlying cancer with appropriate chemotherapy or radiation therapy.
  • Immediate: NS administration to reverse dehydration, increase renal flow, and promote excretion of excess calcium.
  • Lasix may be ordered to block calcium reabsorption in the kidneys; however, it is administered only after dehydration has been corrected.
  • In extremely urgent situations, calcitonin may be administered. Rapid onset, shorter action. Less effective than other antiresorptive therapies. Inhibits osteoclast activity and promotes urinary excretion of calcium.
  • Dialysis may be required if pt is experiencing severe hypercalcemia with renal insufficiency.
  • Nursing care focuses on
    • keeping the pt safe
    • managing symptoms
    • monitoring for side effects of the therapies and minimizing the risk of recurrence.
    • Monitor vs, fluid status, cv status, metal status and neurological status.
    • Place pt on seizure and safety prec (high risk of fractures)
    • Increase pt’s activity and mobility
    • Pain management
    • Stool softeners and antiemetics
    • Due to likelihood of recurrence, educate pt and family on s&s to report to healthcare team.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Superior vena cava syndrome

Definition

A
  • Internal or external obstruction of the SVC causing reduced blood return to the heart.
  • Usually secondary to pulmonary lung or metastatic tumors
  • External pressure: from a tumor or enlarged lymph node
  • Internal pressure: thrombus
    • Decreased blood return to the heart
    • Resulting congestion
    • Decreased CO
    • Life threatening pulmonary and cerebral compromise
  • Not common but often the presenting sign of malignancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Superior vena cava syndrome

Clinical findings

A
  • Upper body edema and venous engorgement ** hallmark signs ** (includes tongue swelling and papilledema)
  • Dyspnea (most common symptom)
  • Cough, hoarseness
  • Tachypnea, stridor, increasing respiratory distress
  • Neck and chest vein distention
  • Hypotension
  • Tightness of the neck (Stokes’ sign)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Superior vena cava syndrome

Diagnostic tests

A
  • Chest radiograph (to confirm a mass)
  • CT scan or MRI (to precisely show location and size of tumor or enlarged lymph nodes)
  • Bipsy/cytology
  • Venogram (to confirm presence of thrombosis)
  • MRI or US may also assist in locating a thrombus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Superior vena cava syndrome

Management

A
  • If malignant disease => radiation therapy or chemotherapy
  • Treatment of choice without tissue diagnosis is irradiation
  • Corticosteroids and diuretics may also be used to decrease inflammation and edema
  • If chronic or recurrent => stenting
  • If r/t catheter thrombosis => thrombolytic therapy (streptokinase, urokinase)
  • Nursing interventions include:
    • Measures to reduce dyspnea
    • Maintain adequate cardiopulmonary function
    • Improve comfort
    • Monitor I&O, vs, mental status and side effects of meds
    • HOB 45
    • Supplemental O2
    • Remove rings, watches, and constricting clothing
    • Avoid invasive or constrictive procedures (venipunctures, IV, BP measurement)
    • Central venous catheter to avoid IV insertion.
    • Maintain a calm, quiet environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Definition

A
  • Condition characterized by excessive production and release of antidiuretic hormone (ADH)
  • It changes body’s fluid and electrolyte balance by INCREASING WATER RETENTION, resulting in hyponatremia.
  • Lung cancer is the most common cause
  • Normal serum Na levels: 135 - 145
  • Severe SIADH can result in cerebral edema and death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SIADH

Clinical findings

A
  • Mild hyponatremia (125 - 134)
    • Thirst
    • h/a, irritability, lethargy, behavioral changes
    • Decreasing UO, weight gain
    • Peripheral edema
    • Muscle cramps
    • Anorexia
  • Moderate hyponatremia (115 - 125)
    • Confusion, irritability, weakness, tremors
    • Combativeness, agitation, hallucinations, areflexia
  • Severe hyponatremia (<115)
    • Seizures, coma
    • Oliguria
    • Respiratory failure, inability to maintain airway or mobilize secretions
    • Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SIADH

Diagnostic tests

A
  • Decreased serum sodium (< 130)
  • Decrease serum osmolality (< 280)
  • Increases of urine sodium (> 20)
  • Increases in urine osmolality (> 300)
  • Hypokalemia, hypomagnesemia, and hypocalcemia due to dilution of plasma
17
Q

SIADH

Management

A
  • TREATMENT OF THE UNDERLYING CAUSE
  • Mild to moderate SIADH - Fluid restriction to 500 to 1000 ml/day only
  • Severe SIADH - May require infusion of 3% hypertonic saline solution to increase water movement from cells to plasma, administered over several hrs
  • Too rapid correction of Na may lead to seizures and death. Correction should not exceed 0.5 to 1 mEq/hr. Furosemide may be administered concurrently to assist with diuresis and prevent fluid overload.
  • Nursing care includes
    • Mgmt of fluids and side effects of hyponatremia and its treatment.
    • Pts must maintain a fluid restriction of 500 to 1000 mL/day
    • Strict I&O
    • DW
    • Labs
    • Seizure prec
18
Q

Tumor Lysis Syndrome

Definition

A
  • Metabolic imbalance resulting from the rapid release of large amounts of intracellular components during cell death
  • It can occur between one and five days after initiation of chemotherapy in pts who have a bulky tumor that is responsive to chemo.
  • Lysing of the tumor releases large amounts of Potassium, Phosphorus, and Uric acid into the blood, which leads to a reciprocal decrease in serum calcium.
  • Commonly associated with hematologic tumors (leukemia and non-Hodgkin’s lymphoma)
  • The resulting metabolic abnormalities include hyperkalemia, hyperphosphatemia, a reciprocal decrease in serum calcium as it binds with phosphorus, and hyperuricemia (from conversion of nucleic acids into uric acid by the liver)
  • Renal failure may occur due to increase formation of uric acid crystals and calcium phosphate salts that obstruct renal flow.
  • Fatal cardiac arrhythmias may result from the hyperkalemia.
  • Death in TLS is most often due to complications of renal failure or cardiac arrest.
19
Q

Tumor Lysis Syndrome

Clinical findings

A
  • Labs: hyperkalemia, hyperphosphatemia, and increased uric acid. Decreased serum calcium and magnesium
  • Elevation of BUN, creatinine clearance
  • Metabolic acidosis
  • Renal: flank pain, decreased UO, hematuria, weight gain, edema
  • Gastrointestinal: nausea, vomiting, anorexia, diarrhea, abdominal cramping, and/or pain
  • Cardiac: dysrhythmias, which are usually atrial
  • Neuromuscular: muscle cramps, tetany, weakness, confusion, seizures. + Chvosteks and Trousseau’s sign.
  • Hyperactive DTRs
  • Unexplained weight gain
20
Q

Tumor Lysis Syndrome

Management

A
  • Early recognition and timely management will greatly minimize severity of its effects
  • Preventive measures include aggressive hydration to dilute the electrolytes and enhance excretion
  • SODIUM BICARBONATE solution may be used to alkalinize the urine, thereby increasing uric acid solubility and minimizing precipitation. IMPORTANT TO MAINTAIN AN ALKALOTIC STATE
  • DIURETICS may be added to promote urine excretion
  • ALLOPURINOL is used to prevent uric acid formation (300 mg daily or BID)
  • Monitor serum electrolytes q 6 to 12 hours to detect increases in potassium or decreases in calcium
  • Once TLS has been identified: Aluminum hydroxide (to bind with phosphate), exchange resins such as sodium polystyrene sulfonate/KAYEXALATE to promote potassium elimination through the feces. Rasburicase to promote uric acid metabolism and excretion in the urine once hyperuricemia exists.
  • If electrolyte abnormalities persist or when renal failure is evident => hemodialysis
  • Nursing management focuses on:
    • Maintenance of fluid and electrolyte balance
    • Monitoring the pt for side effects
    • Education about “paradox of treatment”: While TLS can be a critical outcome of ca treatment, it also suggests tumor is responsive to treatment and may be viewed as a positive sign.
    • Strict I&O
    • Serial weights
    • Frequent assessment for signs of fluid overload
    • Monitor BUN, creatinine, electrolytes
    • Prompt recognition of signs is essential.
  • GOAL IS TO AVOID DIALYSIS
21
Q

Spinal cord compression

Definition

A
  • Neurological emergency resulting from pressure on the spinal cord.
  • It may be due to direct tumor invasion of the spinal cord or tumor invasion of the vertebrae, causing destruction and collapse onto the spinal cord.
  • Usually seen in pts with metastatic breast, lung, prostate, kidney, lymphoma, and multiple myeloma malignancies.
  • Effects range from temporary numbness to devastating paralysis
22
Q

Spinal cord compression

Clinical findings

A
  • Neck or back pain (most common)
  • Pain constant or initiated with movement. Usually worsens with strains on neck and back such as during coughing or sitting up.
  • Tingling and sensory loss (early symptoms)
  • Weakness or paralysis will occur below the level of the cord that is being compressed.
  • Increasing compression = increasing symptoms.
  • Muscle weakness, decreasing DTRs, paralysis, loss of bowel and bladder function.
23
Q

Spinal cord compression

Diagnosis

A
  • Physical exam
  • Pt history
  • CT scan or MRI of spine to confirm the diagnosis.
24
Q

Spinal cord compression

Management

A
  • Goal is to quickly halt or reverse compression
  • Radiation is the treatment of choice
  • Surgical decompression can be used if tumor does not respond to radiation or if area has already been treated with radiation.
  • Corticosteroids may be administered concurrently to reduce edema around area of compression, and pain management is a priority
  • Chemo agents may be used for tumors sensitive to these agents and if radiation or surgery is contraindicated
  • Early recognition and management essential to prevent paralysis.
  • Nursing mgmt focuses on safety, symptom relief and supportive care.
    • Provide a safe environment, especially when moving the pt
    • Implement a comprehensive program for pain mgmt
    • Frequent (every 1 to 2 hrs) assessment of neuromuscular status and monitoring for changes in bowel and bladder function are also essential.
    • Immobility to prevent further damage. Bed rest and logrolling.
    • Implement strategies to prevent complications of immobility (DVT and pressure ulcer prevention)
    • If pt has cervical compression, respiratory assessments and intubation to ensure airway patency will be required.
    • Pain mgmt is also essential. Steroids, NSAIDs, opioids, antidepressants, or anticonvulsants
    • Teaching: S&S to report, rehab services, psychosocial needs.
25
Q

Sepsis/Systemic Inflammatory Response Syndrome (SIRS)

A
  • Inability to regulate inflammatory response
  • Positive bacterial growth in blood culture
  • Hypo/hyperthermia
  • Tachycardia
  • Tachypnea
  • PaCO2 < 32 mmHg
  • PaO2 < 60 mmHg
  • Leukocytopenia(10000)
26
Q

Disseminated Intravascular Coagulation
DIC
Definition

A
  • Syndrome: A complication of a serious, life-threatening condition
  • Characterized by: bleeding and thrombosis results from depletion of clotting factors, platelets, and RBCs
27
Q

DIC

Etiology

A
  • Massive trauma or burns
  • Oncology
  • Direct tissue damage
  • Endothelial injury
  • Sepsis
28
Q

DIC

S&S

A

Two primary pathophysiologic mechanisms: Formation of thrombi and bleeding.

  • Integumentary: Temperature cool and clammy, petechiae, ecchymosis, purpura, and bleeding from breaks in skin integrity
  • Head, eyes, ears, nose, throat: Scleral hemorrhage, epistaxis and bleeding in or around the mouth
  • Cardiovascular: Tachycardia, hypotension, and peripheral edema
  • Respiratory: Hemoptysis, pulmonary congestion, and hypoxia
  • Gastrointestinal: Melena, hematochezia, hematemesis, and hemorrhoidal bleeding.
  • Genitourinary: Hematuria and vaginal bleeding
  • Neurologic: Mental status changes and altered LOC.
29
Q

DIC

Laboratory findings

A
  • D-dimer: Increased
  • PT, PTT, INR: Unusually prolonged but nonspecific
  • Fibrinogen: Decreased
  • Fibrin split products: Increased
  • Antithrombin: Decreased
  • Platelet: Decreased
30
Q

DIC

Management

A

Primary intervention: PREVENTION

Goals once DIC identified:

  • Maintain organ perfusion
  • Slow consumption of coagulation factors
31
Q

Multiple Organ Dysfunction Syndrome

MODS

A
  • Result of DIC
  • Prevent end-organ ischemia, support BP and circulating volume
  • IV fluid, inotropes
  • PRBC’s
  • Platelets
  • Cryoprecipitate
  • FFP
  • Recombinant human protein C
  • Antithrombin III recently approved in US
  • Protease inhibitors
32
Q

MODS

Nursing management

A
  • Support vital functions
  • Initiate bleeding precautions
  • Provide comfort and emotional support
  • Maintain surveillance for complications
33
Q

Pleural effusion

A
  • Cancer pts with SOB are high risk for pleural effusion
  • Confirmed with CXR
  • CT scans are better at detecting fluid
  • US ARE ALSO GOOD AT DETECTING FLUID
  • Categories
    • Transudative: Clear
    • Exudative: Cloudy
  • S&S
    • Tachypneic
    • Labored breathing
    • Dull or flat instead of resonance
    • Lung sounds diminished
    • Pleural friction rub
  • Treatment
    • Thorosynthesis is the next step.
    • One lung at a time if both are affected.